Analysis

Lunai Bioworks Inc. (LNAI) Stock Analysis

Lunai Bioworks Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to LNAI.

websiteLNAI/analysis/LNAI

Lunai Bioworks Inc.

Lunai Bioworks Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to LNAI.

Stock profile

Ticker

LNAI

Asset type

Stock

Market cap

$17.1M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Lunai Bioworks Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • LNAI primary listing
  • 2Q50
  • A41K8P

Latest Lunai Bioworks Inc. news

Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration

Lunai Bioworks' (NASDAQ: LNAI) wholly owned subsidiary BioSymetrics and BrainStorm Therapeutics today announced a strategic collaboration and Letter of Intent (LOI) to jointly d...

LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT

Lunai Bioworks, Inc. (Nasdaq: LNAI) (the "Company") today announced that it will effect a reverse stock split of its issued and outstanding common stock, par value $0.0001 per s...

Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP

Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced the completion of a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties, ex...

Lunai Bioworks, Inc. Announces Postponement of Special Meeting of Stockholders to May 8, 2026

Lunai Bioworks Inc. (NASDAQ:LNAI) SACRAMENTO, CA, UNITED STATES, April 28, 2026 /⁨EINPresswire.com⁩/ -- Lunai Bioworks, Inc. (Nasdaq: LNAI) (the “Company”)

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

Lunai Bioworks, Inc. (NASDAQ: LNAI) ("Lunai"), an AI-driven drug discovery company, and Geneial, Inc., a precision medicine data infrastructure and patient engagement company, t...

Research sections

Valuation

Review valuation context for Lunai Bioworks Inc..

Future growth

Review future growth context for Lunai Bioworks Inc..

Past performance

Review past performance context for Lunai Bioworks Inc..

Financial health

Review financial health context for Lunai Bioworks Inc..

Dividend

Review dividend context for Lunai Bioworks Inc..

Management

Review management context for Lunai Bioworks Inc..

Ownership

Review ownership context for Lunai Bioworks Inc..

Other information

Review other information context for Lunai Bioworks Inc..

Community

Review community context for Lunai Bioworks Inc..